Physician profile
Eric A Secemsky
NPI 1942535489
$1,154,244.01
in general payments reported to CMS, 2019-2025
52 companies · $349K in 2025
The $349K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $45K · 2020: $70K · 2021: $96K · 2022: $153K · 2023: $255K · 2024: $185K · 2025: $349K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $444K · Acquisitions: $134K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $82K · Travel and Lodging: $76K · Food and Beverage: $19K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $16K · Honoraria: $16K · Grant: $2,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $444,198.71 |
| Acquisitions | $133,510.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $82,362.50 |
| Travel and Lodging | $76,159.80 |
| Food and Beverage | $19,291.68 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $16,350.00 |
| Honoraria | $15,650.00 |
| Grant | $2,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $297,910.44 | 2020-2025 | General - Therapies, Clinical Trial Product, Eluvia |
| Medtronic, INC. | $185,756.46 | 2021-2025 | Symplicity G3, Hawkone, In.Pact Admiral |
| Philips North America LLC | $139,682.97 | 2019-2025 | (9520) Igt Devices Undivided, Igt Devices Undivided, (Bh4) Igt Devices Undivided |
| Bard Peripheral Vascular, INC. | $92,505.35 | 2019-2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon, Venovo |
| Shockwave Medical, INC | $45,601.05 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $39,665.96 | 2019-2025 | Xience Skypoint, Amplatzer, Supera |
| Venturemed Group, INC. | $38,590.99 | 2020-2024 | Flex Vessel Prep System |
| Medtronic Vascular, INC. | $37,413.74 | 2019-2020 | |
| Cardiovascular Systems INC. | $32,952.18 | 2019-2023 | Diamondback Coronary, Diamondback Peripheral |
| E.R. Squibb & Sons, L.L.C. | $30,475.00 | 2023-2025 | Eliquis |
| Cordis US Corp. | $27,167.16 | 2023-2025 | Selution Slr Pta, Cardio, Selution Slrpcta |
| W. L. Gore & Associates, INC. | $23,267.44 | 2024-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Viabahn Endoprosthesis With Propaten Bioactive Surface, Gore Viabahn Endoprosthesis With Heparin |
| Laminate Medical Technologies INC. | $19,371.97 | 2023 | Vasq External Support |
| Cook Incorporated | $18,862.50 | 2020-2023 | Zilver Ptx, Cook |
| Terumo Medical Corporation | $14,948.73 | 2022-2025 | Angio-Seal, Glidewire, Glidesheath Slender |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veryan Medical Incorporated | $14,000.00 | 2022-2025 | Biomimics 3d Vascular Stent System |
| Penumbra, INC. | $12,080.45 | 2024-2025 | Indigo System |
| Bayer Healthcare Pharmaceuticals INC. | $8,802.50 | 2020-2022 | |
| Surmodics, INC. | $8,800.00 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8,609.54 | 2022-2025 | Lifevest |
| Siemens Medical Solutions USA, INC. | $8,393.30 | 2024-2025 | Artis Icono Floor |
| Janssen Pharmaceuticals, INC | $7,716.98 | 2020 | |
| Asahi Intecc USA, INC. | $5,687.28 | 2025 | Asahi Coronary Wires, Pv Wires, Asahi Peripheral Vascular Wires |
| Contego Medical, INC | $5,156.93 | 2024 | Neuroguard |
| Inquis Medical, INC. | $5,000.00 | 2025 | Aventus |
| Regeneron Pharmaceuticals, INC. | $4,499.48 | 2025 | |
| Janssen Scientific Affairs, LLC | $3,000.00 | 2020 | |
| Cook Medical LLC | $2,674.14 | 2019-2025 | Zilver Ptx, Cook Celect |
| Zoll Medical Corporation | $2,621.62 | 2023 | |
| Teleflex LLC | $2,250.00 | 2024-2025 | |
| Heartflow, INC. | $1,937.15 | 2023-2025 | Ffrct |
| Infraredx, INC. | $1,500.00 | 2025 | |
| Inari Medical, INC. | $1,245.25 | 2020-2022 | |
| Endologix LLC | $1,200.00 | 2024 | Endocross Device, Torus Stent Graft System |
| Microvention, INC. | $1,020.00 | 2024-2025 | Web Aneurysm Embolization System |
| Endovascular Engineering INC. | $856.22 | 2025 | Helo Thrombectomy System |
| Inspiremd Ltd | $727.00 | 2023-2024 | Cguard, Cguard |
| Asahi Intecc Co., Ltd. | $619.76 | 2025 | |
| Angiodynamics, INC. | $519.01 | 2019-2025 | Auryon Laser System 100-120 Vac, Alphavac |
| Ge Healthcare | $361.23 | 2025 | |
| Becton, Dickinson and Company | $357.21 | 2025 | |
| Recor Medical INC | $223.22 | 2024-2025 | Paradise Ultrasound Renal Denervation System, Paradise Renal Denervation System |
| Biotronik INC. | $101.79 | 2022 | |
| Reflow Medical INC | $24.53 | 2024-2025 | |
| Thrombolex, INC. | $22.06 | 2024 | Bashir Endovascular Catheter |
| Haemonetics Corporation | $21.69 | 2025 | Teg6s Hemostasis System |
| Cathworks, INC. | $15.22 | 2024 | Ffrangio |
| Astrazeneca Pharmaceuticals Lp | $15.00 | 2019 | |
| Nipro Medical Corporation | $13.51 | 2025 | Makoto |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$474,765.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$3,565.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Secemsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.